After a stellar FY24 performance, Natco Pharma’s stock has taken a hit. What’s next for the company as it faces crucial ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

Get detailed information on Olaparib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Olaparib monotherapy may be a treatment option for some patients with high-risk biochemically recurrent prostate cancer, according to researchers.

San Antonio - Researchers from Dana-Farber Cancer Institute will present more than 30 research studies at the 47th annual San ...

AstraZeneca Pharma India Limited has received permission to import for sale and distribution in Form CT-20 from the CDSCO, ...

In a regulatory filing, the company said it has received permission from the Central Drugs Standard Control Organisation ...

This approval establishes the use of Olaparib in combination with Durvalumab as a maintenance treatment for adult patients ...

The Central Drugs Standard Control Organisation granted approval for the drug's use in combination with Durvalumab for the ...